TNGX
Price:
$30.94
Market Cap:
$3.85B
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., foc...[Read more]
Industry
Biotechnology
IPO Date
2020-09-03
Stock Exchange
NASDAQ
Ticker
TNGX
According to Tango Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -41.54%. This represents a change of 298.59% compared to the average of -10.42% of the last 4 quarters.
The mean historical ROE of Tango Therapeutics, Inc. over the last ten years is -72.58%. The current -41.54% ROE has changed -42.77% with respect to the historical average. Over the past ten years (40 quarters), TNGX's ROE was at its highest in in the September 2025 quarter at 9.93%. The ROE was at its lowest in in the June 2020 quarter at -34213.96%.
Average
-72.58%
Median
-43.36%
Minimum
-178.30%
Maximum
-16.89%
Discovering the peaks and valleys of Tango Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 156.70%
Maximum Annual ROE = -16.89%
Minimum Annual Increase = -87.45%
Minimum Annual ROE = -178.30%
| Year | ROE | Change |
|---|---|---|
| 2025 | -29.35% | -55.06% |
| 2024 | -65.31% | 62.47% |
| 2023 | -40.20% | -7.30% |
| 2022 | -43.36% | 156.70% |
| 2021 | -16.89% | -87.45% |
| 2020 | -134.64% | -24.49% |
The current ROE of Tango Therapeutics, Inc. (TNGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-44.95%
5-year avg
-39.02%
10-year avg
-72.58%
Tango Therapeutics, Inc.’s ROE is greater than Septerna, Inc. (-9.44%), less than UroGen Pharma Ltd. (121.52%), less than ProKidney Corp. (7.40%), greater than EyePoint Pharmaceuticals, Inc. (-110.54%), greater than Bicara Therapeutics Inc. Common Stock (-35.89%), greater than Kodiak Sciences Inc. (-253.85%), greater than Kura Oncology, Inc. (-141.95%), greater than Nurix Therapeutics, Inc. (-64.21%), greater than Xencor, Inc. (-28.77%), greater than Fortrea Holdings Inc. (-79.12%),
| Company | ROE | Market cap |
|---|---|---|
| -9.44% | $1.62B | |
| 121.52% | $1.45B | |
| 7.40% | $551.46M | |
| -110.54% | $1.09B | |
| -35.89% | $1.19B | |
| -253.85% | $1.80B | |
| -141.95% | $803.41M | |
| -64.21% | $1.47B | |
| -28.77% | $914.17M | |
| -79.12% | $1.56B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tango Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tango Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Tango Therapeutics, Inc.'s ROE?
How is the ROE calculated for Tango Therapeutics, Inc. (TNGX)?
What is the highest ROE for Tango Therapeutics, Inc. (TNGX)?
What is the 3-year average ROE for Tango Therapeutics, Inc. (TNGX)?
What is the 5-year average ROE for Tango Therapeutics, Inc. (TNGX)?
How does the current ROE for Tango Therapeutics, Inc. (TNGX) compare to its historical average?